Supplementary Files
Keywords
Psychosocial problems, Intellectual issues, Thalassemia children, Pediatric symptom checklist
Dual therapy, hybrid therapy,
How to Cite
Abstract
Objective: Iron deficiency is the most common nutritional deficiency worldwide. Common causes of iron deficiency anaemia (IDA) in children are excessive consumption of cow’s milk and prolonged breastfeeding with delayed and poor weaning. The objective of this study is to assess the effectiveness of intravenous iron in children with IDA, with poor compliance to oral iron therapy. This study aims to determine the mean levels of Hb after IV iron therapy in children with iron deficiency anaemia having a poor response to oral iron therapy.
Subjects and Methods: It was a descriptive study. The study was conducted at the Department of Paediatric Medicine, Fatima Memorial Hospital, Lahore. A Total of 119 children fulfilling the selection criteria were enrolled in the study. The absolute dosage of iron was divided into 2 doses administered over two consecutive days. Each IV iron dose was diluted in 100 ml of normal saline in a micro-burette and infused over two hours. Patients were followed up at four weeks to check for haemoglobin levels. All the collected data were entered and analysed by using SPSS v25.0.
Results: A total 119 patients with Iron deficiency anemia (IDA) were enrolled in this study. There were 61(51.3%) males and 58(48.7%) females. Age range in this study was from 6 months to 12 years with a mean age of 7.5±1.5 years. Mean duration of IDA was 8.5±2.3 months. Mean Hb level at baseline was 8.16±0.911 g/dl and 10.76±1.023 g/dl after 4 weeks of treatment and the difference was statistically significant with p-value of 0.001.
Conclusion: Intravenous iron therapy is effective and safe to raise the haemoglobin levels in children with IDA who showed poor compliance to oral iron therapy.
Keywords: Anaemia, Iron-Deficiency, Pediatric, Haemoglobins, Iron, Intravenous
References
Braat S, Fielding KL, Han J, Jackson VE, Zaloumis S, Xu JXH, et al. Haemoglobin thresholds to define anaemia from age 6 months to 65 years: estimates from international data sources. Lancet Haematol. 2024;11(4):e253–64. https://doi.org/10.1016/S2352-3026(24)00030-9
Simanjuntak SPP, Saragih JRP. Relationship between anaemia and pneumonia severity in children aged 29 days to 5 years. Int J Health Med Sci. 2024;7(2):30–4.
Dessie G, Li J, Nghiem S, Doan T. Prevalence and determinants of stunting-anemia and wasting-anemia comorbidities and micronutrient deficiencies in children under 5 in the least-developed countries: a systematic review and meta-analysis. Nutr Rev. 2024;00(0):1–17. https://doi.org/10.1093/nutrit/nuae017
Kapoor A, Baig F, Channa NA, Othman SS, Abualhamael SA, Baig M. Estimation of calories intake, iron, zinc, and selenium among children of the underprivileged area in Sindh, Pakistan. PLoS One. 2024;19(6):e0304277. https://doi.org/10.1371/journal.pone.0304277
Dehghani A, Molani-Gol R, Rafraf M, Mohammadi-Nasrabadi F, Khodayari-Zarnaq R. Iron deficiency anemia status in Iranian pregnant women and children: an umbrella systematic review and meta-analysis. BMC Pregnancy Childbirth. 2024;24(1):1–12. https://doi.org/10.1186/s12884-024-06342-3
Iolascon A, Andolfo I, Russo R, Sanchez M, Busti F, Swinkels D, et al. Recommendations for diagnosis, treatment, and prevention of iron deficiency and iron deficiency anemia. HemaSphere. 2024;8(7):e1087. https://doi.org/10.1097/HS9.0000000000001087
Abramowitz BR, Saba H, Meier RR, Binyamin A, Md RA, Md HS, et al. Iron deficiency anemia as a potential risk factor for poor outcomes in acute pancreatitis. [Preprint]. 2024;0–18.
Li J, Wang L, Wang Z, Zhao F, Sun Y, Lu Y, et al. Association between suicide attempts and anemia in late-life depression inpatients. BMC Geriatr. 2024;24(1):1–7. https://doi.org/10.1186/s12877-024-04631-y
Baig MMA, Batool S, Aslam T, Rafique M, Batool S, Anwaar O, et al. Efficacy and safety of intravenous iron in children with iron deficiency anaemia poorly compliant to oral iron therapy. J Ayub Med Coll. 2022;34(2):317–20.
Boucher AA, Bedel A, Jones S, Lenahan SF, Geer R, McGann PT. A retrospective study of the safety and efficacy of low molecular weight iron dextran for children with iron deficiency anemia. Pediatr Blood Cancer. 2021;68(7):e29024. https://doi.org/10.1002/pbc.29024.
Onyeneho NG, Anzaku SA, Okeke TC, Ohayi SAR, Okeke OF. Comparative effectiveness of intravenous iron sucrose and oral iron therapy in the treatment of iron deficiency anemia in pregnancy in a Nigerian tertiary hospital: A randomized clinical trial. PLOS ONE. 2023;18(7):e0287567. https://doi.org/10.1371/journal.pone.0287567
Boynito WG, Diongue O, Temesgen K, Yeshitila YG, Tessema GY, De Souza M, et al. Effectiveness of video-based health education on breastfeeding practices among infants aged 0–6 months in Dirashe District, South Ethiopia: a cluster randomized controlled trial. Hum Behav Emerg Technol. 2024;2024. https://doi.org/10.1155/2024/6678912
Ragab SM, Kamal TM, Badr MA, Taha R, Al-Haggar MS. Efficacy and safety of intravenous ferric carboxymaltose in children with iron deficiency anemia unresponsive to oral iron. Pediatr Hematol Oncol. 2021;38(7–8):599–608. https://doi.org/10.1080/08880018.2021.1925381
Sabe R, Vatsayan A, Mahran A, Khalili AS, Ahuja S, Sferra TJ. Safety and efficacy of intravenous iron sucrose for iron-deficiency anemia in children and adolescents with inflammatory bowel disease. Glob Pediatr Health. 2019;6:1–7. https://doi.org/10.1177/2333794X19867947
Nazir F, Khurshid A, Talib MA. Intravenous iron sucrose in malnourished children with iron deficiency anemia. Prof Med J. 2020;27(09):1867–71.
Kaur R, Kant S, Subramanian M, Kamble BD, Malhotra S, Haldar P. Effectiveness of intravenous iron sucrose therapy in routine antenatal care for the treatment of moderate to severe anemia among pregnant women attending a secondary care hospital in North India: a retrospective analysis. Cureus. 2022;14(3):e23179. https://doi.org/10.7759/cureus.23179
Zaman S, Shah SA, Jehanzeb K, Sabir S, Rashid HU. Effect of intravenous iron therapy on serum ferritin and haemoglobin levels in children reporting with iron deficiency anaemia. J Pak Med Assoc. 2020;70(5):1344–8.
Caimmi S, Crisafulli G, Franceschini F, Liotti L, Bianchi A, Bottau P, et al. Hypersensitivity to intravenous iron preparations. Children (Basel). 2022;9(10):1–10. https://doi.org/10.3390/children9101565
Onken JE, Bregman DB, Harrington RA, Morris D, Acs P. Safety and efficacy of ferric derisomaltose for iron deficiency anemia: A pooled analysis of randomized controlled trials. Clin Hematol Int. 2021;3(2):76–85. https://doi.org/10.2991/chi.k.210118.001.
Kalra PA, Bhandari S, Angulo E, Gaillard C, Abdel-Gadir A, Macdougall IC. A systematic literature review of intravenous iron therapy and infections. Clin Kidney J. 2020;13(6):1044–59. https://doi.org/10.1093/ckj/sfaa016.
Kazancı EG, Korkmaz MF, Orhaner B. Efficacy and safety of intravenous iron sucrose treatment in children with iron deficiency anemia. Med Sci Discov. 2020;7(9):317–21.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyright (c) 2025 Muhammad Hasan Raza, Muhammad Usman, Mahnoor, Mohsin Mahmood